CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3023% above fair value
$79.81−1.36 (-1.68%)
Close on Nov 12, 2026Market cap $4.19BP/E 33.4Yield –
CareDx profit margin
Profit margin (net margin) is net income as a percentage of revenue.
CareDx's profit margin for the twelve months ending Sep 30, 2026 was 25.9%. For fiscal 2025 it was -5.6%, against 15.7% the year before. The highest annual figure on record is 15.7% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -5.6% | −21.4 |
| FY2024 | Dec 31, 2024 | 15.7% | +83.6 |
| FY2023 | Dec 31, 2023 | -67.9% | −44.1 |
| FY2022 | Dec 31, 2022 | -23.8% | −13.5 |
| FY2021 | Dec 31, 2021 | -10.3% | −0.6 |
| FY2020 | Dec 31, 2020 | -9.7% | +7.6 |
| FY2019 | Dec 31, 2019 | -17.3% | +43.8 |
| FY2018 | Dec 31, 2018 | -61.1% | +53.7 |
| FY2017 | Dec 31, 2017 | -114.8% | −17.6 |
| FY2016 | Dec 31, 2016 | -97.1% | −48.4 |
| FY2015 | Dec 31, 2015 | -48.7% | −51.6 |
| FY2014 | Dec 31, 2014 | 2.9% | +18.9 |
| FY2013 | Dec 31, 2013 | -16.0% | +8.7 |
| FY2012 | Dec 31, 2012 | -24.7% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 13.8% | +12.2 |
| Q2 FY2026 | Jun 30, 2026 | 83.8% | +93.7 |
| Q1 FY2026 | Mar 31, 2026 | 2.4% | +14.6 |
| Q4 FY2025 | Dec 31, 2025 | -3.8% | −105.1 |
| Q3 FY2025 | Sep 30, 2025 | 1.7% | +14.5 |
| Q2 FY2025 | Jun 30, 2025 | -9.9% | −4.9 |
| Q1 FY2025 | Mar 31, 2025 | -12.2% | +15.4 |
| Q4 FY2024 | Dec 31, 2024 | 101.3% | +281.4 |
| Q3 FY2024 | Sep 30, 2024 | -12.8% | +22.1 |
| Q2 FY2024 | Jun 30, 2024 | -5.0% | +30.5 |
| Q1 FY2024 | Mar 31, 2024 | -27.6% | +3.1 |
| Q4 FY2023 | Dec 31, 2023 | -180.1% | −157.9 |
| Q3 FY2023 | Sep 30, 2023 | -35.0% | −13.6 |
| Q2 FY2023 | Jun 30, 2023 | -35.5% | −8.6 |
| Q1 FY2023 | Mar 31, 2023 | -30.7% | −6.0 |
| Q4 FY2022 | Dec 31, 2022 | -22.2% | −1.9 |
| Q3 FY2022 | Sep 30, 2022 | -21.3% | −5.6 |
| Q2 FY2022 | Jun 30, 2022 | -26.9% | −24.3 |
| Q1 FY2022 | Mar 31, 2022 | -24.7% | −23.7 |
| Q4 FY2021 | Dec 31, 2021 | -20.4% | −14.4 |
| Q3 FY2021 | Sep 30, 2021 | -15.7% | −10.5 |
| Q2 FY2021 | Jun 30, 2021 | -2.6% | +13.1 |
| Q1 FY2021 | Mar 31, 2021 | -1.0% | +14.2 |
| Q4 FY2020 | Dec 31, 2020 | -6.0% | +7.3 |
| Q3 FY2020 | Sep 30, 2020 | -5.3% | +0.1 |
| Q2 FY2020 | Jun 30, 2020 | -15.7% | +9.3 |
| Q1 FY2020 | Mar 31, 2020 | -15.2% | +13.8 |
| Q4 FY2019 | Dec 31, 2019 | -13.3% | +2.6 |
| Q3 FY2019 | Sep 30, 2019 | -5.4% | +88.9 |
| Q2 FY2019 | Jun 30, 2019 | -24.9% | +54.0 |
| Q1 FY2019 | Mar 31, 2019 | -29.0% | +34.8 |
| Q4 FY2018 | Dec 31, 2018 | -16.0% | +237.3 |
| Q3 FY2018 | Sep 30, 2018 | -94.3% | +22.8 |
| Q2 FY2018 | Jun 30, 2018 | -78.9% | −46.0 |
| Q1 FY2018 | Mar 31, 2018 | -63.8% | −15.8 |
| Q4 FY2017 | Dec 31, 2017 | -253.3% | −110.7 |
| Q3 FY2017 | Sep 30, 2017 | -117.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -32.9% | – |
| Q1 FY2017 | Mar 31, 2017 | -48.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -142.6% | – |
See a number that looks wrong?